Enovis Co. (NYSE:ENOV) Shares Bought by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. raised its holdings in Enovis Co. (NYSE:ENOV) by 4.5% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,737 shares of the company’s stock after purchasing an additional 458 shares during the period. PNC Financial Services Group Inc.’s holdings in Enovis were worth $471,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the company. Inceptionr LLC bought a new stake in shares of Enovis in the 4th quarter valued at approximately $813,000. Raymond James Financial Inc. bought a new stake in shares of Enovis in the 4th quarter valued at approximately $16,407,000. Arizona State Retirement System increased its holdings in shares of Enovis by 2.6% in the 4th quarter. Arizona State Retirement System now owns 16,208 shares of the company’s stock valued at $711,000 after acquiring an additional 414 shares during the last quarter. Live Oak Investment Partners bought a new stake in shares of Enovis in the 4th quarter valued at approximately $1,062,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Enovis by 7.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 645,789 shares of the company’s stock valued at $28,337,000 after acquiring an additional 44,970 shares during the last quarter. 98.45% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Separately, Needham & Company LLC lowered their price objective on Enovis from $65.00 to $64.00 and set a “buy” rating for the company in a research note on Thursday, February 27th.

Enovis Price Performance

Shares of ENOV opened at $39.41 on Thursday. Enovis Co. has a 12 month low of $35.14 and a 12 month high of $62.79. The company has a market cap of $2.24 billion, a P/E ratio of -17.99 and a beta of 2.05. The stock has a fifty day moving average price of $42.97 and a 200 day moving average price of $43.59. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12.

Enovis (NYSE:ENOV) last released its quarterly earnings results on Wednesday, February 26th. The company reported $0.98 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.06. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. The company had revenue of $560.98 million during the quarter, compared to analysts’ expectations of $555.14 million. On average, research analysts forecast that Enovis Co. will post 2.79 earnings per share for the current year.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.